Publicacións en colaboración con investigadores/as de Institute Catalá Oncología (3)

2024

  1. Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment

    Biomedicine and Pharmacotherapy, Vol. 176

2023

  1. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

    Cells, Vol. 12, Núm. 6

  2. Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy

    Nature communications, Vol. 14, Núm. 1, pp. 746